COPD (Chronic Obstructive Pulmonary Disease) and Asthma are two respiratory conditions that can cause difficulty breathing, coughing, and wheezing. There are several devices available to help manage these conditions and improve breathing function.
Inhalers: Inhalers are the most common devices used to treat COPD and Asthma. These devices deliver medication directly to the lungs, where it is needed. Inhalers come in different types, including metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and soft mist inhalers. Inhalers work by creating a fine mist or powder that is inhaled into the lungs.
The global COPD and asthma devices market size was estimated at $36.45 billion in 2019, and is anticipated to hit $51.62 billion by 2027, registering a CAGR of 4.3% from 2020 to 2027.
Download Sample Copy of this Report:
www.alliedmarketresearch.com/request-sample/579
Nebulizers: Nebulizers are devices that convert liquid medication into a fine mist that can be inhaled through a mask or mouthpiece. Nebulizers are often used by people who have difficulty using inhalers or for those who need higher doses of medication.
Peak Flow Meters: Peak Flow Meters are handheld devices that measure how well air moves out of the lungs. They are used to monitor lung function and to help people with Asthma or COPD identify changes in breathing function before symptoms appear.
Oxygen Therapy Devices: For people with severe COPD or Asthma, oxygen therapy devices may be necessary to deliver supplemental oxygen. These devices include oxygen tanks, oxygen concentrators, and portable oxygen tanks.
Spirometers: Spirometers are devices that measure lung function by measuring how much air is breathed in and out of the lungs. They can be used to diagnose COPD or Asthma, monitor lung function over time, and help people with these conditions develop a breathing plan.
It is important to work with a healthcare provider to determine which devices are best for managing COPD or Asthma symptoms. They can also provide guidance on how to use these devices properly and monitor lung function over time.
COVID-19 impact-
The demand for respiratory care devices including inhalers has been increased during Covid-19. Also, the international regulatory agencies have accelerated approval of several respiratory devices.
The global lockdown has disrupted the supply chain badly and as a result, the manufacturing process has also been severely hampered.
However, government bodies across the world have imposed certain relaxations to ease up the existing regulations and the global market is projected to retrieve its position soon.
For Purchase Enquiry at:
www.alliedmarketresearch.com/purchase-enquiry/579
The segments used in COPD and Asthma devices vary depending on the type of device. Here are the common segments for each type of device:
Inhalers: Inhalers usually consist of a canister, which contains the medication, and a plastic mouthpiece. The segments used in inhalers include the canister, mouthpiece, actuator, dose counter (in some inhalers), and cap.
Nebulizers: Nebulizers consist of a compressor, nebulizer cup, and tubing. The segments used in nebulizers include the compressor, nebulizer cup, tubing, mask or mouthpiece, and medication chamber.
Peak Flow Meters: Peak Flow Meters typically consist of a plastic meter with a mouthpiece. The segments used in peak flow meters include the meter, mouthpiece, and scale.
Oxygen Therapy Devices: Oxygen therapy devices vary in design and segments, but the common segments include oxygen tank, regulator, flow meter, humidifier bottle (in some devices), and nasal cannula or mask.
Spirometers: Spirometers consist of a handheld device with a mouthpiece and a display screen. The segments used in spirometers include the mouthpiece, display screen, and data storage capacity (in some devices).
Overall, these segments are designed to deliver medication, measure lung function, and provide supplemental oxygen for people with COPD or Asthma. It is important to understand how to use each device and its segments properly to get the most benefit from them.
North America garnered the major share in 2019 -
Based on geography, North America garnered the largest share in 2019, holding more than one-third of the global COPD and asthma devices market. This is owing to the widespread and early adoption of inhalers & nebulizers and large pool of patients suffering from respiratory diseases in this region. However, the region across Asia-Pacific would portray the fastest CAGR of 5.0% by 2027, due to rise in healthcare expenditure, growth in awareness of advanced portable COPD & asthma devices, and increase in disposable income in Asia-Pacific region.
Request Customization:
www.alliedmarketresearch.com/request-for-customization/579
Leading market players analysed in the research include
GF Health Products
GlaxoSmithKline Plc
Koninklijke Philips N.V.
Novartis AG
PARI medical Holding GMBH
Smith's Group Plc.
Aerogen, Inc.
AstraZeneca PLC
Baxter International Inc.
Boehringer Ingelheim International GmbH
3M COMPANY
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
